Your browser doesn't support javascript.
loading
The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence.
Maspero, Marianna; Yilmaz, Sumeyye; Cazzaniga, Beatrice; Raj, Roma; Ali, Khaled; Mazzaferro, Vincenzo; Schlegel, Andrea.
Afiliación
  • Maspero M; Transplantation Center, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Yilmaz S; General Surgery and Liver Transplantation Unit, IRCCS Istituto Tumori, Milan, Italy.
  • Cazzaniga B; Transplantation Center, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Raj R; Transplantation Center, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Ali K; Transplantation Center, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Mazzaferro V; Transplantation Center, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Schlegel A; General Surgery and Liver Transplantation Unit, IRCCS Istituto Tumori, Milan, Italy.
JHEP Rep ; 5(11): 100846, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37771368
ABSTRACT
The risk of cancer recurrence after liver surgery mainly depends on tumour biology, but preclinical and clinical evidence suggests that the degree of perioperative liver injury plays a role in creating a favourable microenvironment for tumour cell engraftment or proliferation of dormant micro-metastases. Understanding the contribution of perioperative liver injury to tumour recurrence is imperative, as these pathways are potentially actionable. In this review, we examine the key mechanisms of perioperative liver injury, which comprise mechanical handling and surgical stress, ischaemia-reperfusion injury, and parenchymal loss leading to liver regeneration. We explore how these processes can trigger downstream cascades leading to the activation of the immune system and the pro-inflammatory response, cellular proliferation, angiogenesis, anti-apoptotic signals, and release of circulating tumour cells. Finally, we discuss the novel therapies under investigation to decrease ischaemia-reperfusion injury and increase regeneration after liver surgery, including pharmaceutical agents, inflow modulation, and machine perfusion.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: JHEP Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: JHEP Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos